Fundraising FoxParadigm
2 known investors
Find your way into Paradigm
Sign up to see every warm intro you have to Paradigm
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paradigm team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions. The company operates in the cancer diagnostics and genomics industry.
Investors · 2
Frequently asked questions
- What does Paradigm do?
- Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions. The company operates in the cancer diagnostics and genomics industry.
- Who are Paradigm's investors?
- Paradigm's investors include BlueStone Venture Partners, New Science Ventures.